$AI
C3.ai, Inc. Stock $ai

$ai Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-K Financial Statement

#000162828021012990 Filed on June 25, 2021

Income Statement

Concept	2020 Q2	2019 Q2	2019
Revenue	$41.62M	$23.74M	$91.61M
YoY Change	75.32%
Cost Of Revenue	$9.510M	$8.340M	$30.39M
YoY Change	14.03%
Gross Profit	$32.11M	$15.40M	$61.22M
YoY Change	108.51%
Gross Profit Margin	77.15%	64.87%	66.83%
Selling, General & Admin	$44.90M	$19.05M	$59.94M
YoY Change	135.7%
% of Gross Profit	139.83%	123.7%	97.92%
Research & Development	$17.43M	$10.79M	$37.32M
YoY Change	61.54%
% of Gross Profit	54.28%	70.06%	60.96%
Depreciation & Amortization	$940.0K		$550.0K
YoY Change
% of Gross Profit	2.93%		0.9%
Operating Expenses	$62.33M	$29.83M	$97.26M
YoY Change	108.95%
Operating Profit	-$30.22M	-$14.43M	-$36.04M
YoY Change	109.42%
Interest Expense	$1.140M	$950.0K	$4.500M
YoY Change	20.0%
% of Operating Profit
Other Income/Expense, Net	-$1.250M	-$100.0K	-$546.0K
YoY Change	1150.0%
Pretax Income	-$30.34M	-$13.58M	-$33.08M
YoY Change	123.42%
Income Tax	$100.0K	$70.00K	$266.0K
% Of Pretax Income
Net Earnings	-$30.43M	-$13.65M	-$33.35M
YoY Change	122.93%
Net Earnings / Revenue	-73.11%	-57.5%	-36.4%
Basic Earnings Per Share
Diluted Earnings Per Share	-$315.9K	-$141.7K	-$345.8K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q2	2019 Q2	2019
SHORT-TERM ASSETS
Cash & Short-Term Investments			$156.5M
YoY Change
Cash & Equivalents	$33.10M	$98.61M	$98.60M
Short-Term Investments			$57.90M
Other Short-Term Assets			$3.800M
YoY Change
Inventory
Prepaid Expenses
Receivables	$30.83M		$63.50M
Other Receivables			$0.00
Total Short-Term Assets	$281.2M		$223.8M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$8.723M		$7.300M
YoY Change
Goodwill	$625.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments			$33.50M
YoY Change
Other Assets	$13.83M		$2.200M
YoY Change
Total Long-Term Assets	$23.90M		$43.70M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$281.2M		$223.8M
Total Long-Term Assets	$23.90M		$43.70M
Total Assets	$305.1M		$267.5M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.726M		$5.700M
YoY Change
Accrued Expenses	$9.083M		$16.30M
YoY Change
Deferred Revenue	$53.54M
YoY Change
Short-Term Debt			$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$81.04M		$102.2M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt			$0.00
YoY Change
Other Long-Term Liabilities	$6.001M		$12.00M
YoY Change
Total Long-Term Liabilities	$6.001M		$12.00M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$81.04M		$102.2M
Total Long-Term Liabilities	$6.001M		$12.00M
Total Liabilities	$93.80M		$114.2M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$293.6M
YoY Change
Common Stock	$110.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$182.7M	-$165.4M	$153.3M
YoY Change
Total Liabilities & Shareholders Equity	$305.1M		$267.5M
YoY Change

Cashflow Statement

Concept	2020 Q2	2019 Q2	2019
OPERATING ACTIVITIES
Net Income	-$30.43M	-$13.65M	-$33.35M
YoY Change	122.93%
Depreciation, Depletion And Amortization	$940.0K		$550.0K
YoY Change
Cash From Operating Activities	-$58.56M		-$34.88M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures	-$670.0K		$6.811M
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$162.8M		-$89.42M
YoY Change
Cash From Investing Activities	-$163.5M		-$96.23M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.240M		$54.47M
YoY Change
NET CHANGE
Cash From Operating Activities	-58.56M		-$34.88M
Cash From Investing Activities	-163.5M		-$96.23M
Cash From Financing Activities	1.240M		$54.47M
Net Change In Cash	-220.8M		-$76.63M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$58.56M		-$34.88M
Capital Expenditures	-$670.0K		$6.811M
Free Cash Flow	-$57.89M		-$41.69M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001577526
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-04-30
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201609Member
CY2020Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1667
CY2019Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2020Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2021Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M24D
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2021	ai	Common Stock Automatic Conversion Anniversary Period If Circumstances Met CommonStockAutomaticConversionAnniversaryPeriodIfCircumstancesMet	P20Y
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39744
CY2021	dei	Entity Registrant Name EntityRegistrantName	C3.ai, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3999357
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	1300 Seaport Blvd,
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Redwood City,
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94063
CY2021	dei	City Area Code CityAreaCode	650
CY2021	dei	Local Phone Number LocalPhoneNumber	503-2200
CY2021	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.001 per share
CY2021	dei	Trading Symbol TradingSymbol	AI
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	4300000000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	115355000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33104000	USD
CY2021Q2	us-gaap	Short Term Investments ShortTermInvestments	978020000	USD
CY2020Q2	us-gaap	Short Term Investments ShortTermInvestments	211874000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	812000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	755000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	65460000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30827000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14302000	USD
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5400000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	1173137000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	281205000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6133000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8723000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	625000	USD
CY2020Q2	us-gaap	Goodwill Goodwill	625000	USD
CY2021Q2	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2020Q2	us-gaap	Long Term Investments LongTermInvestments	725000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16582000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13830000	USD
CY2021Q2	us-gaap	Assets Assets	1196477000	USD
CY2020Q2	us-gaap	Assets Assets	305108000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	12075000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4726000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21829000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13693000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	72263000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	53537000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18318000	USD
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9083000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	124485000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	81039000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2964000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	6758000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7853000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6001000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	135302000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	93798000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3499992	shares
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1410325000	USD
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	110485000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	81000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	424000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-349333000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-293637000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1061175000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-182697000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1196477000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	305108000	USD
CY2021Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	15180000	USD
CY2020Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	250000	USD
CY2021Q2	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	56000	USD
CY2020Q2	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	0	USD
CY2021Q2	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	4895000	USD
CY2020Q2	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	0	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	183217000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	156666000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	91605000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	44519000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	38787000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	30386000	USD
CY2021	us-gaap	Gross Profit GrossProfit	138698000	USD
CY2020	us-gaap	Gross Profit GrossProfit	117879000	USD
CY2019	us-gaap	Gross Profit GrossProfit	61219000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	96991000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	94974000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	37882000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	68856000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	64548000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37318000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33109000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29854000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22061000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	198956000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	189376000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	97261000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-60258000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-71497000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-36042000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	1255000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	4251000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	3508000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4011000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1752000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-546000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54992000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-68998000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33080000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	704000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	380000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	266000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-55696000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-69378000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-33346000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-55696000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-69378000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-33346000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-343000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	350000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	75000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-56039000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-69028000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33271000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	-139830000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1839000	USD
CY2019	ai	Apic Share Based Payment Arrangement Increase For Stock Options Early Exercised APICShareBasedPaymentArrangementIncreaseForStockOptionsEarlyExercised	1561000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4267000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	75000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-33346000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-165434000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44027000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2321000	USD
CY2020	ai	Apic Share Based Payment Arrangement Increase For Stock Options Early Exercised APICShareBasedPaymentArrangementIncreaseForStockOptionsEarlyExercised	655000	USD
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3548000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8310000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	350000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1061175000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-55696000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-69378000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-182697000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-182697000	USD
CY2021	ai	Apic Increase For Collection Of Finance Receivable APICIncreaseForCollectionOfFinanceReceivable	1457000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	418553000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10717000	USD
CY2021	ai	Apic Share Based Payment Arrangement Increase For Stock Options Early Exercised APICShareBasedPaymentArrangementIncreaseForStockOptionsEarlyExercised	2869000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21740000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-55696000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-69378000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-33346000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4297000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1302000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	550000	USD
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3315000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3052000	USD
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	21740000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	8310000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	4267000	USD
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	USD
CY2020	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	1025000	USD
CY2019	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	180000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	657000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-534000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34690000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-32659000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	46144000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	14855000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4265000	USD
CY2019	ai	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1677000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	7450000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1219000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	48000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	8135000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	651000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4170000	USD
CY2021	ai	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3551000	USD
CY2020	ai	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3174000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	11549000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1343000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-533000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	14933000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-30930000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	37255000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37553000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-61281000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34876000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1628000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2298000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6811000	USD
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0	USD
CY2020	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	581000	USD
CY2019	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0	USD
CY2021	ai	Proceeds From Sale Of Equity Securities Without Readily Determinable Fair Value ProceedsFromSaleOfEquitySecuritiesWithoutReadilyDeterminableFairValue	725000	USD
CY2020	ai	Proceeds From Sale Of Equity Securities Without Readily Determinable Fair Value ProceedsFromSaleOfEquitySecuritiesWithoutReadilyDeterminableFairValue	0	USD
CY2019	ai	Proceeds From Sale Of Equity Securities Without Readily Determinable Fair Value ProceedsFromSaleOfEquitySecuritiesWithoutReadilyDeterminableFairValue	0	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1152142000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	219853000	USD
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	166303000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	385893000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	98659000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	76886000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-767152000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-124073000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-96228000	USD
CY2021	ai	Proceeds From Issuance Initial Public Offering And Private Placements ProceedsFromIssuanceInitialPublicOfferingAndPrivatePlacements	851859000	USD
CY2020	ai	Proceeds From Issuance Initial Public Offering And Private Placements ProceedsFromIssuanceInitialPublicOfferingAndPrivatePlacements	0	USD
CY2019	ai	Proceeds From Issuance Initial Public Offering And Private Placements ProceedsFromIssuanceInitialPublicOfferingAndPrivatePlacements	0	USD
CY2021	ai	Proceeds From Repayment Of Shareholder Loan ProceedsFromRepaymentOfShareholderLoan	26003000	USD
CY2020	ai	Proceeds From Repayment Of Shareholder Loan ProceedsFromRepaymentOfShareholderLoan	0	USD
CY2019	ai	Proceeds From Repayment Of Shareholder Loan ProceedsFromRepaymentOfShareholderLoan	0	USD
CY2021	ai	Payments For Repurchase Of Common Stock And Stock Options PaymentsForRepurchaseOfCommonStockAndStockOptions	0	USD
CY2020	ai	Payments For Repurchase Of Common Stock And Stock Options PaymentsForRepurchaseOfCommonStockAndStockOptions	3548000	USD
CY2019	ai	Payments For Repurchase Of Common Stock And Stock Options PaymentsForRepurchaseOfCommonStockAndStockOptions	0	USD
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	7179000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	44027000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	16673000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4203000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2905000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	887356000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	119851000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	54472000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	82651000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-65503000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-76632000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33604000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99107000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	175739000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	417000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	116255000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33604000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99107000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	115355000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33104000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98607000	USD
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	900000	USD
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	500000	USD
CY2019Q2	us-gaap	Restricted Cash RestrictedCash	500000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	116255000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33604000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99107000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	550000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	660000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	131000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	212000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	60000	USD
CY2021	ai	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	105000	USD
CY2020	ai	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	0	USD
CY2019	ai	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	0	USD
CY2021	ai	Share Based Payment Arrangement Vesting Of Early Exercised Stock Options ShareBasedPaymentArrangementVestingOfEarlyExercisedStockOptions	2869000	USD
CY2020	ai	Share Based Payment Arrangement Vesting Of Early Exercised Stock Options ShareBasedPaymentArrangementVestingOfEarlyExercisedStockOptions	655000	USD
CY2019	ai	Share Based Payment Arrangement Vesting Of Early Exercised Stock Options ShareBasedPaymentArrangementVestingOfEarlyExercisedStockOptions	1561000	USD
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	7200000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers and estimating variable consideration, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.</span></div>
CY2021	us-gaap	Fiscal Period FiscalPeriod	Fiscal YearThe Company’s fiscal year ends on April 30.
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	500000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents, investments and accounts receivable. The majority of the Company’s cash and cash equivalents are held by one financial institution. The Company is exposed to that financial institution to the extent that its cash balance with that financial institution is in excess of Federal Deposit Insurance Company (“FDIC”) insurance limits. The Company’s investment policy is to invest in securities with a minimum rating of P1 by Moody’s, A1 by Standard & Poor’s, F-1 by Fitch’s or higher for short-term investments, and minimum rating of A2 by Moody’s, A by Standard & Poor’s, or A by Fitch’s or higher for long-term investments.</span></div>
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	900000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	800000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	800000	USD
CY2021Q2	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	3800000	USD
CY2020Q2	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	500000	USD
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P5Y
CY2020	us-gaap	Advertising Expense AdvertisingExpense	29200000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	5200000	USD
CY2021	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranties</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s offerings are warranted to perform in a manner consistent with industry standards.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s arrangements generally include provisions for indemnifying customers against liabilities if its services infringe on a third party’s intellectual property rights. They also generally include service-level agreements warranting defined levels of uptime reliability and performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the Company has not incurred material costs as a result of its warranties and indemnifications. There are no accrued liabilities related to these obligations on the consolidated financial statements.</span></div>
CY2021Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	0	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	35300000	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11500000	USD
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	12400000	USD
CY2019Q2	us-gaap	Deferred Rent Credit DeferredRentCredit	900000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	183217000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	156666000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	91605000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	72263000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	53537000	USD
CY2020	ai	Contract With Customer Liability Increase For Invoicing Prior To Satisfaction Of Performance Obligation ContractWithCustomerLiabilityIncreaseForInvoicingPriorToSatisfactionOfPerformanceObligation	52163000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2964000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	6758000	USD
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	75227000	USD
CY2020Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	60295000	USD
CY2019Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	91225000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-83093000	USD
CY2020Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	60295000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-57542000	USD
CY2021	ai	Contract With Customer Liability Increase For Invoicing Prior To Satisfaction Of Performance Obligation ContractWithCustomerLiabilityIncreaseForInvoicingPriorToSatisfactionOfPerformanceObligation	72474000	USD
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	75227000	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	293800000	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	145200000	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1200000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1000000.0	USD
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1100000	USD
CY2021Q2	ai	Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost	1021340000	USD
CY2021	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2020	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2019	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	101000	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	20000	USD
CY2021Q2	ai	Cash Cash Equivalents And Available For Sale Debt Securities CashCashEquivalentsAndAvailableForSaleDebtSecurities	1021421000	USD
CY2020Q2	ai	Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost	222708000	USD
CY2020Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	425000	USD
CY2020Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q2	ai	Cash Cash Equivalents And Available For Sale Debt Securities CashCashEquivalentsAndAvailableForSaleDebtSecurities	223133000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	8	investment
CY2020Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	16	investment
CY2020Q2	ai	Debt Securities Available For Sale Other Than Temporary Impaired Number Of Investments DebtSecuritiesAvailableForSaleOtherThanTemporaryImpairedNumberOfInvestments	0	investment
CY2021Q2	ai	Debt Securities Available For Sale Other Than Temporary Impaired Number Of Investments DebtSecuritiesAvailableForSaleOtherThanTemporaryImpairedNumberOfInvestments	0	investment
CY2019Q2	ai	Debt Securities Available For Sale Other Than Temporary Impaired Number Of Investments DebtSecuritiesAvailableForSaleOtherThanTemporaryImpairedNumberOfInvestments	0	investment
CY2021	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2020Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	700000	USD
CY2020	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	1000000.0	USD
CY2020Q4	ai	Proceeds From Sale Of Equity Securities Without Readily Determinable Fair Value ProceedsFromSaleOfEquitySecuritiesWithoutReadilyDeterminableFairValue	700000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11536000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10582000	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5403000	USD
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1859000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6133000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8723000	USD
CY2021	us-gaap	Depreciation Depreciation	4000000.0	USD
CY2020	us-gaap	Depreciation Depreciation	1200000	USD
CY2019	us-gaap	Depreciation Depreciation	500000	USD
CY2021Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	12216000	USD
CY2020Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	8356000	USD
CY2021Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	3935000	USD
CY2020Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	2823000	USD
CY2021Q2	ai	Accrued Payroll Taxes And Employee Benefits Current AccruedPayrollTaxesAndEmployeeBenefitsCurrent	3405000	USD
CY2020Q2	ai	Accrued Payroll Taxes And Employee Benefits Current AccruedPayrollTaxesAndEmployeeBenefitsCurrent	1397000	USD
CY2021Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1863000	USD
CY2020Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	515000	USD
CY2021Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	410000	USD
CY2020Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	602000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21829000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13693000	USD
CY2021Q2	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	5331000	USD
CY2020Q2	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	2243000	USD
CY2021Q2	ai	Accrued General Expenses Current AccruedGeneralExpensesCurrent	3588000	USD
CY2020Q2	ai	Accrued General Expenses Current AccruedGeneralExpensesCurrent	1466000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3894000	USD
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3533000	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5505000	USD
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1841000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18318000	USD
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9083000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	3793000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	3825000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1568000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1324000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	1589000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	1542000	USD
CY2021	us-gaap	Lease Cost LeaseCost	6950000	USD
CY2020	us-gaap	Lease Cost LeaseCost	6691000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	4031000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	3946000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5094000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8409000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3894000	USD
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3533000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1735000	USD
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5647000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	5629000	USD
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	9180000	USD
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4152000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1756000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	USD
CY2021Q2	ai	Lessee Operating Lease Liability To Be Paid Year Five And After Year Five LesseeOperatingLeaseLiabilityToBePaidYearFiveAndAfterYearFive	0	USD
CY2021	ai	Long Term Purchase Commitment Incurred Cost LongTermPurchaseCommitmentIncurredCost	14300000	USD
CY2020	ai	Long Term Purchase Commitment Incurred Cost LongTermPurchaseCommitmentIncurredCost	4400000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5908000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	279000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	5629000	USD
CY2019	ai	Long Term Purchase Commitment Incurred Cost LongTermPurchaseCommitmentIncurredCost	3400000	USD
CY2021	ai	Temporary Equity Dividend Rate Percentage TemporaryEquityDividendRatePercentage	0.06
CY2020	us-gaap	Dividends Cash DividendsCash	0	USD
CY2019	us-gaap	Dividends Cash DividendsCash	0	USD
CY2021	us-gaap	Dividends Cash DividendsCash	0	USD
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	ai	Share Based Payment Arrangement Expense Difference Between Repurchase Price And Fair Value ShareBasedPaymentArrangementExpenseDifferenceBetweenRepurchasePriceAndFairValue	24900000	USD
CY2021	ai	Common Stock Automatic Conversion Period One If Circumstances Met CommonStockAutomaticConversionPeriodOneIfCircumstancesMet	P6M
CY2021	ai	Common Stock Automatic Conversion Period Two If Circumstances Met CommonStockAutomaticConversionPeriodTwoIfCircumstancesMet	P6M
CY2021	ai	Proceeds From Share Based Payment Arrangement Vesting Of Early Exercised Stock Options ProceedsFromShareBasedPaymentArrangementVestingOfEarlyExercisedStockOptions	6000000.0	USD
CY2020	ai	Proceeds From Share Based Payment Arrangement Vesting Of Early Exercised Stock Options ProceedsFromShareBasedPaymentArrangementVestingOfEarlyExercisedStockOptions	1900000	USD
CY2019	ai	Proceeds From Share Based Payment Arrangement Vesting Of Early Exercised Stock Options ProceedsFromShareBasedPaymentArrangementVestingOfEarlyExercisedStockOptions	1100000	USD
CY2021Q2	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	5300000	USD
CY2020Q2	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	2200000	USD
CY2019Q4	ai	Stock Repurchased During Period Price Per Share StockRepurchasedDuringPeriodPricePerShare	30.2310
CY2019Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	28500000	USD
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23372000	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.46
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y11M23D
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	50679000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16619000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.86
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1809000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.34
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5305000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.84
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	32877000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.48
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10D
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	116962000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	14504000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.50
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5799000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.90
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3095000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.89
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	38487000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.39
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y11M23D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2304714000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	13290000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.35
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M18D
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	835990000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	39578000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	6.35
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y11M23D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2371708000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.17
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	137300000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	15000000.0	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.438
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.386
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.004
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.017
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21740000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8310000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4267000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-58407000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-69887000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-33868000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3415000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	889000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	788000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54992000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-68998000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33080000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	267000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	286000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	113000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	418000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	264000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	704000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	380000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	266000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	704000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	380000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	266000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11628000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-14489000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6947000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	286000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	113000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-299000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	85000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	306000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	694000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	530000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	389000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	30587000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14837000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6587000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-17667000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-23000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	337000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	35000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	242000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	207000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	704000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	84000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	145000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	163000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	380000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	266000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	889000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	2081000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	4053000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	3174000	USD
CY2021Q2	ai	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	1323000	USD
CY2020Q2	ai	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	2235000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1258000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	2959000	USD
CY2021Q2	ai	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	1588000	USD
CY2020Q2	ai	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	1365000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	73189000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	40242000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4778000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3617000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3690000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2628000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	327000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	7000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	91095000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	58294000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	88015000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55812000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2046000	USD
CY2021Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3080000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3080000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2482000	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1883000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	436000	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1197000	USD
CY2020Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2482000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	88000000.0	USD
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55800000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	32200000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4048000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-33346000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4048000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3037000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1285000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1011000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5333000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021Q2	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	USD
CY2021Q2	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-55696000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-69378000	USD

Files In Submission

Name	View Source	Status
0001628280-21-012990-index-headers.html	Edgar Link	pending
0001628280-21-012990-index.html	Edgar Link	pending
0001628280-21-012990.txt	Edgar Link	pending
0001628280-21-012990-xbrl.zip	Edgar Link	pending
a302certification-ceo10xk.htm	Edgar Link	pending
a302certification-cfo10xk.htm	Edgar Link	pending
a906certification-ceo10xk.htm	Edgar Link	pending
a906certification-cfo10xk.htm	Edgar Link	pending
ai-20210430.htm	Edgar Link	pending
ai-20210430.xsd	Edgar Link	pending
ai-20210430_cal.xml	Edgar Link	unprocessable
ai-20210430_def.xml	Edgar Link	unprocessable
ai-20210430_g1.jpg	Edgar Link	pending
ai-20210430_htm.xml	Edgar Link	completed
ai-20210430_lab.xml	Edgar Link	unprocessable
ai-20210430_pre.xml	Edgar Link	unprocessable
exhibit1021.htm	Edgar Link	pending
exhibit211.htm	Edgar Link	pending
exhibit231.htm	Edgar Link	pending
exhibit421.htm	Edgar Link	pending
exhibit44.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AI
C3.ai, Inc. Stock $ai

2020 Q2 Form 10-K Financial Statement

#000162828021012990 Filed on June 25, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AI C3.ai, Inc. Stock $ai

2020 Q2 Form 10-K Financial Statement

#000162828021012990 Filed on June 25, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AI
C3.ai, Inc. Stock $ai